Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Clinical trial NCT01620489 · COMPLETED
Trial details
- NCT number
- NCT01620489
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-14
- Primary completion
- 2013-08-20
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.